Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development) – Funding Decisions Notification (April 2009 Competition: 200904PDD)

(Alternate Title: Proof of Principle Program Phase I - Drug Development)

The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development) competition.

Funding Opportunity Summary

The objectives of the funding opportunity "Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development)" were to facilitate the advancement of promising drug compounds discovered in academia, focusing on:

• target validation
• lead compound validation
• lead compound optimization

Funding Competition Summary

A total of 9 applications were received of which 3 were approved for funding.

Contact Information

For further information about this competition, please contact:

Edit Palencsar
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-946-0095
Fax: 613-954-1800
Email: edit.palencsar@cihr-irsc.gc.ca

For further information about this initiative and the objectives of this funding opportunity please contact:

Chaidwick Leneis
Senior KSE Specialist
Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-941-4437
Fax: 613-954-1800
Email: chaidwick.leneis@cihr-irsc.gc.ca

Funding Decisions Data Report

Access the "Proof of Principle Program Phase I - Drug Development" funding decisions data report.